[Late drug-induced hyperkalemia in a patient with congestive heart failure]
- PMID: 16463712
[Late drug-induced hyperkalemia in a patient with congestive heart failure]
Abstract
Patients with congestive heart failure are at risk for hiperkaliemia because of coexisting comorbidities and use of multiple medications that impair potassium excretion--such as angiotensin-converting enzyme inhibitors or spironolactone. This is the case report about the patient with late drug-induced hyperkalemia. Causes and prevention methods used against development of this adverse event were explained.
Similar articles
-
[Drug-related hyperkalemia resulted from spironolactone and angiotensin converting enzyme inhibitors therapy].Pol Merkur Lekarski. 1999 Aug;7(38):69-70. Pol Merkur Lekarski. 1999. PMID: 10522422 Polish.
-
Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.J Clin Pharm Ther. 2005 Dec;30(6):603-10. doi: 10.1111/j.1365-2710.2005.00694.x. J Clin Pharm Ther. 2005. PMID: 16336294 Clinical Trial.
-
[Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].Praxis (Bern 1994). 2000 Dec 7;89(49):2073-6. Praxis (Bern 1994). 2000. PMID: 11190849 German.
-
New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia.Expert Opin Drug Saf. 2005 Jul;4(4):677-88. doi: 10.1517/14740338.4.4.677. Expert Opin Drug Saf. 2005. PMID: 16011447 Review.
-
Heart failure.Clin Evid. 2002 Jun;(7):57-78. Clin Evid. 2002. Update in: Clin Evid. 2002 Dec;(8):60-81. PMID: 12230638 Updated. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical